KPV: Molecular Characterization and Conformational Chemistry — A Research Reference

The sequence is lysine-proline-valine, positions 11 through 13 of alpha-MSH, the thirteen-residue melanocortin peptide. Locating that tail against the rest of the parent is the first thing worth establishing: the region the melanocortin receptors engage is the central histidine-phenylalanine-arginine-tryptophan motif at positions 6 through 9, and this tripeptide lies wholly outside it. The melanocortin analogues elsewhere in this catalogue — built by constraining that core motif — are therefore structurally unrelated to this fragment beyond sharing a parent [1].

Each residue contributes something distinct. Lysine carries a basic side-chain amine, giving the molecule its positive charge and much of its water solubility. Proline is the one amino acid whose side chain closes back onto its own backbone nitrogen, forming a rigid ring that restricts rotation. Valine contributes a compact branched hydrophobic side chain. The commonly supplied form carries free amino and carboxyl termini, with a molecular weight of approximately 342 daltons.

For a three-residue peptide the interesting structural question is whether it adopts any preferred conformation at all, and here that has been examined directly. Conformational analysis of the acetylated, amidated form of this tripeptide — the C-terminal sequence of alpha-MSH — characterized the geometries accessible to the chain and the role of the central proline in restricting them [2]. Proline in the middle position of a tripeptide is the dominant conformational determinant: it eliminates a backbone hydrogen-bond donor and constrains the preceding residue's accessible angles, so a Lys-Pro-Val chain samples a far narrower conformational space than its length alone would suggest.

The second characterized recognition event is transport rather than receptor binding. This tripeptide is a substrate for PepT1, an intestinal proton-coupled oligopeptide transporter that carries di- and tripeptides across epithelial membranes; uptake by that route was demonstrated directly and shown to be transporter-dependent [3]. That is a substrate-transporter interaction, not a signalling one, and it makes transporter expression in the chosen cell system a primary experimental variable — a monolayer lacking PepT1 will not accumulate the peptide regardless of medium composition.

Comparative work across alpha-MSH and its C-terminal tripeptides has catalogued the biochemistry of this fragment family relative to the full-length parent [1].

Mass spectrometry confirms the intact molecular mass near 342 daltons and, at the resolution routinely achieved on so small a molecule, cleanly distinguishes the free acid from the amidated form — which differ by roughly one dalton and are both catalogued.

Reversed-phase HPLC resolves the main peak from related substances and yields the purity figure. A three-residue synthesis has few opportunities for deletion, so the impurity profile is usually simple. The sequence-specific consideration is that the chain opens with a residue followed by proline: sequences beginning X-proline are prone during synthesis to diketopiperazine formation, in which the first two residues cyclize into a six-membered ring and detach, leaving truncated material. It is chromatographically visible and a known consideration for this class of sequence.

One analytical property follows from composition: the sequence contains no aromatic residues and so has essentially no absorbance at the 280-nanometre wavelength used to quantify most peptides by ultraviolet light. Detection relies on backbone absorbance near 214 nanometres instead, and any measurement built on 280-nanometre readings is uninformative for this compound.

Net peptide content accounts for counter-ions and residual water, determining how much peptide a nominal milligram figure represents.

Sealed lyophilized material is stable at ambient temperature for the duration of transit and requires no cold chain in shipping. On receipt, vials are refrigerated and kept out of direct light.

Reconstituted material is held refrigerated and used within the window the receiving facility's protocols specify, and repeated freeze-thaw cycling is avoided.

By composition this is one of the more robust entries in the catalogue: no cysteine or methionine removes the common oxidation routes, no asparagine or glutamine removes deamidation, and no tryptophan removes the usual photosensitivity concern. A charged tripeptide is also about as undemanding as peptide handling gets — it dissolves rapidly in aqueous media, presents essentially no surface for aggregation, and requires no mechanical assistance. The standard handling above is applied as a matter of discipline rather than because the molecule is fragile.

KPV is an investigational compound. It has not been approved by the FDA or any other regulatory authority, and no manufacturing, labeling, or quality standards for an approved product apply to it. Research material is sold strictly for laboratory research use; it must not be administered to humans or animals. Researchers are responsible for compliance with all institutional and jurisdictional requirements governing research chemicals.

Each batch of research-grade KPV is accompanied by an independent certificate of analysis specific to that lot.

KPV is the tripeptide lysine-proline-valine, corresponding to positions 11 through 13 of alpha-MSH and lying entirely outside the parent's receptor-engaging core motif, with a molecular weight near 342 daltons in the free-acid form. Its conformational space is dominated by the central proline and has been characterized directly, and it is a demonstrated substrate for the proton-coupled oligopeptide transporter PepT1 — a transport interaction rather than a receptor one. Analytical verification rests on mass discrimination of acid from amide, chromatographic attention to diketopiperazine truncation, detection at 214 rather than 280 nanometres, and batch-specific net peptide content.